|
Market Closed -
OTC Markets
22:37:29 23/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 40.45 USD | +9.15% |
|
+9.15% | -16.20% |
Company Valuation: COSMOS Pharmaceutical Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 483,107 | 525,081 | 502,890 | 700,001 | 476,495 | 492,108 | - | - |
| Change | - | 8.69% | -4.23% | 39.2% | -31.93% | 3.28% | - | - |
| Enterprise Value (EV) 1 | 450,132 | 497,354 | 477,918 | 692,920 | 476,495 | 520,533 | 529,727 | 535,408 |
| Change | - | 10.49% | -3.91% | 44.99% | -31.23% | 9.24% | 1.77% | 1.07% |
| P/E | 20.9x | 22.1x | 20.6x | 22.6x | 14.9x | 15.3x | 14.4x | 13.5x |
| PBR | 2.54x | 2.49x | 2.17x | 2.72x | 1.68x | 1.59x | 1.46x | 1.35x |
| PEG | - | 7.98x | 7.61x | 0.8x | 4.32x | 100.5x | 2.3x | 2.03x |
| Capitalization / Revenue | 0.64x | 0.63x | 0.52x | 0.69x | 0.43x | 0.42x | 0.39x | 0.36x |
| EV / Revenue | 0.6x | 0.6x | 0.5x | 0.69x | 0.43x | 0.44x | 0.42x | 0.39x |
| EV / EBITDA | 10x | 10.5x | 9.29x | 11.1x | 7.12x | 7.37x | 7x | 6.6x |
| EV / EBIT | 15.1x | 16.5x | 15.2x | 17.1x | 11.3x | 11.8x | 11.2x | 10.6x |
| EV / FCF | -39.1x | 93.5x | -222x | -807x | -20.6x | -65.9x | -183x | -845x |
| FCF Yield | -2.56% | 1.07% | -0.45% | -0.12% | -4.85% | -1.52% | -0.55% | -0.12% |
| Dividend per Share 2 | 40 | 50 | 60 | 70 | 82 | 85.3 | 90.01 | 94.2 |
| Rate of return | 0.66% | 0.75% | 0.95% | 0.79% | 1.36% | 1.37% | 1.45% | 1.52% |
| EPS 2 | 292.4 | 300.5 | 308.6 | 390.9 | 404.3 | 404.9 | 430.3 | 459 |
| Distribution rate | 13.7% | 16.6% | 19.4% | 17.9% | 20.3% | 21.1% | 20.9% | 20.5% |
| Net sales 1 | 755,414 | 827,697 | 964,989 | 1,011,390 | 1,099,583 | 1,182,344 | 1,271,788 | 1,369,821 |
| EBITDA 1 | 44,906 | 47,496 | 51,425 | 62,633 | 66,929 | 70,584 | 75,645 | 81,080 |
| EBIT 1 | 29,796 | 30,128 | 31,501 | 40,404 | 42,353 | 44,273 | 47,144 | 50,404 |
| Net income 1 | 23,155 | 23,797 | 24,454 | 30,978 | 32,046 | 32,103 | 34,113 | 36,374 |
| Net Debt 1 | -32,975 | -27,727 | -24,972 | -7,081 | - | 28,425 | 37,619 | 43,300 |
| Reference price 2 | 6,100.00 | 6,630.00 | 6,345.00 | 8,832.00 | 6,012.00 | 6,209.00 | 6,209.00 | 6,209.00 |
| Nbr of stocks (in thousands) | 79,198 | 79,198 | 79,258 | 79,257 | 79,257 | 79,257 | - | - |
| Announcement Date | 11/07/22 | 10/07/23 | 12/07/24 | 11/07/25 | 13/07/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 20.5x | 0.35x | 5.55x | 2.25% | 6.17B | ||
| 15.33x | 0.44x | 7.37x | 1.37% | 3.13B | ||
| 14.37x | 0.36x | 5.27x | 1.51% | 2.88B | ||
| 12.77x | 0.42x | 5.3x | 3.8% | 2.7B | ||
| 19.13x | 0.74x | 10.31x | 1.65% | 2.31B | ||
| 14.67x | 0.45x | 4.28x | 3.81% | 1.47B | ||
| Average | 16.13x | 0.46x | 6.35x | 2.4% | 3.11B | |
| Weighted average by Cap. | 16.94x | 0.43x | 6.26x | 2.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 3349 Stock
- CSMYF Stock
- Valuation COSMOS Pharmaceutical Corporation
Select your edition
All financial news and data tailored to specific country editions
















